Chevron Left
Retour à Développement de médicaments

Avis et commentaires pour d'étudiants pour Développement de médicaments par Université de Californie à San Diego

4.7
étoiles
2,024 évaluations

À propos du cours

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Development course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug development. In this course you will learn the different stages of clinical development as well as the regulatory including but not limited to, an Investigational New Drug Application (IND), New Drug Application (NDA), and product labeling. Additionally you will learn how to Incorporate study design methods for consideration in the design of clinical protocols to assess safety, tolerability, and efficacy in multiple therapeutic areas. In this course you will learn the different phases of clinical development: * Phase 1 or early stage clinical trial are conducted primar­ily to determine how the new drug works in humans, its safety profile and to predict its dosage range. It typically involves between 30 and 100 healthy volunteers. * Phase 2 or Proof of Concept POC studies test for efficacy as well as safety and side effects in a group of between 30 to 200 hundred patients with the disease for which the new drug is being developed. * Phase 3 or late stage clinical development involve much larger group of patients, between a few hundred to thousands, depending on the indication, which will help determine if the new drug can be considered both safe and effective. It will involve control groups using placebo and/or current treatment as a comparison. * Product registration and approval process after a drug is considered safe and effective from Phase 3 trials, it must be authorized in each individual country before it can be marketed. All data gen­erated about the small molecule or biologic is collected and submitted to the regulatory authorities in the US at the FDA, Food and Drug Administration FDA, in Europe the EMA or European Medicines Agency, Japan Ministry of Health and other countries which may require their own national approvals. This course is intended as part 2 of a series: Drug Discovery (https://www.coursera.org/learn/drug-discovery), Drug Development and Drug Commercialization (https://www.coursera.org/learn/drug-commercialization). We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place....

Meilleurs avis

KR

24 mai 2020

I am really glad to have course offered by california university . Its really helpful for me. And i am thankful to all lecturer, and teachers to explain overall drug development process.

Thank you!

HG

15 oct. 2018

Very well done and informative. I truly appreciate the Drug process in entirety being broken down into sections that are easy to comprehend. It is obvious the speakers were chosen for their knowledge.

Filtrer par :

326 - 350 sur 410 Avis pour Développement de médicaments

par James D

15 janv. 2019

par Lavanya

25 févr. 2020

par Jan B

26 févr. 2019

par KONDAPAKA S

7 mai 2020

par Nadia C

30 janv. 2020

par Aderbal A

18 avr. 2021

par Yury K

2 déc. 2019

par Hiep X N

5 août 2017

par abbas a

28 mai 2020

par 树

24 août 2022

par Vindhya S R

6 nov. 2020

par Gaurav P

16 sept. 2022

par Morongwa

26 mars 2020

par Ugbosu F O

27 mai 2021

par INMACULADA R L

10 sept. 2020

par shubham b

21 sept. 2021

par Matthew K

3 août 2017

par Avishek S

27 août 2020

par Alex

25 avr. 2019

par Mahesh W

21 févr. 2022

par ABHISHEK S

5 nov. 2020

par Pao-Sheng C

2 mars 2017

par Rekhakumari C

17 août 2020

par VIHAN S

21 juin 2020

par Hesham E

26 mai 2020